港股异动 | 金山软件涨逾3% 金山办公于科创板上市事宜获批准
格隆汇10月28日丨金山软件(3888.HK)现报19.1港元,涨3.8%,暂成交4298.9万港元,最新总市值262.2亿港元。金山软件上周四(24日)晚间发公告称,有关北京办公软件普通股建议分拆及上市,根据于10月24日在中国证监会网站刊发的注册结果公告,建议于科创板上市的注册已根据法律程序获中国证监会批准。北京办公软件及其建议于科创板上市承销商将与上交所进一步讨论及确认北京办公软件上市时间表,并相应刊发相关上市文件。此外据悉,南下资金近期持续流入金软,港股通累计持仓比例自7月底的16.34%逐步升至8月底的18.08%,再至9月底的22.86%,及至上周三(10月23日)的23.36%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.